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Multiple specialised goose-type 
lysozymes potentially compensate 
for an exceptional lack of chicken-
type lysozymes in Atlantic cod
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Ronny Helland5, David M. Irwin6 & Inge W. Nilsen7
Previous analyses of the Atlantic cod genome showed unique combinations of lacking and expanded 
number of genes for the immune system. The present study examined lysozyme activity, lysozyme 
gene distribution and expression in cod. Enzymatic assays employing specific bacterial lysozyme 
inhibitors provided evidence for presence of g-type, but unexpectedly not for c-type lysozyme activity. 
Database homology searches failed to identify any c-type lysozyme gene in the cod genome or in 
expressed sequence tags from cod. In contrast, we identified four g-type lysozyme genes (LygF1a-d) 
constitutively expressed, although differentially, in all cod organs examined. The active site glutamate 
residue is replaced by alanine in LygF1a, thus making it enzymatic inactive, while LygF1d was found in 
two active site variants carrying alanine or glutamate, respectively. In vitro and in vivo infection by the 
intracellular bacterium Francisella noatunensis gave a significantly reduced LygF1a and b expression but 
increased expression of the LygF1c and d genes as did also the interferon gamma (IFNγ) cytokine. These 
results demonstrate a lack of c-type lysozyme that is unprecedented among vertebrates. Our results 
further indicate that serial gene duplications have produced multiple differentially regulated cod g-type 
lysozymes with specialised functions potentially compensating for the lack of c-type lysozymes.
The vertebrate immune system has evolved two defense systems in response to infectious agents; the innate and 
the adaptive immune response. Innate immunity encompasses a large set of first-line defense factors also includ-
ing antimicrobial peptides and enzymes. The adaptive system involves the on-set of serial responses resulting in a 
long-term memorised defence including production of specific antibodies and T-cells (reviewed in1).
Several studies have revealed that the Atlantic cod, Gadus morhua, possess a unique immune system. Two 
decades ago, it was shown that the immunoglobulin concentration in cod serum is higher than in fish such as 
Atlantic salmon (Salmo salar)2. In 2005, it was hypothesised that the histocompatibility complex class II (MHCII) 
was absent3, which was later confirmed by genome sequencing4. MHCII is an acknowledged key element in the 
humoral immune response and in vaccine efficacy, yet cod, despite the loss of MHCII, produce specific antibodies 
including a strong antibody response to intracellular bacteria like Francisella noatunensis5. In parallel to the find-
ing of a missing MHCII, a highly expanded family of histocompatibility complex class I (MHCI) genes was iden-
tified4. Additionally, cod is the first sequenced vertebrate identified to have lost all orthologs of the mammalian 
cell surface bacterial recognising Toll-like receptor (TLR) genes and instead harbour an expanded ‘fish-specific’ 
TLR family6,7 that could, at least partly, compensate for the abnormalities in the innate immune system. In spite 
of these genetic irregularities, cod is not especially susceptible to common fish diseases although francisellosis, a 
granulomatous disease caused by the facultative intracellular bacterium F. noatunensis, is an emerging disease of 
particular relevance to the aquaculture sector8.
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For decades, the designation lysozyme was typically perceived as a synonym for the chicken (c-) type, which 
was originally found in the hen egg white. Although the goose (g-) type lysozyme was discovered more than 
50 years ago9, g-types were believed to be exclusive to avian species. In 2001, it was revealed that g-type lysozymes 
also exist in fish10, the first such finding in non-bird species. Indications of a wider distribution of g-type 
lysozymes came by the finding of g-type genes and enzymes in urochordates11 and mammals12. Recent progress 
in genome research and sequence analyses has established that g-type lysozymes are as commonly distributed as 
chicken (c- ) type lysozymes in the animal kingdom13–15.
Lysozymes or muramidases, play an important role in the innate immune system and catalyse the hydrolysis 
of the 1,4-beta-linkages between N-acetylmuramic acid (NAM) and N-acetyl-D-glucosamine (NAG) residues 
in bacterial cell wall peptidoglycans16. Ibrahim et al.17 also gave evidence for retained antibacterial activity for 
lysozymes catalytically inactivated by substitution of an active site residue. In addition, previous reports have 
shown antibacterial activity for proteolytic fragments of both lysozymes18.
The antibacterial significance of lysozymes is further reflected by the presence of lysozyme-specific protein 
inhibitors in a wide variety of bacteria. The bacterial inhibitor of vertebrate lysozyme (Ivy) shows efficient inhibi-
tion of c-type lysozymes, and to a certain degree also of g-type and phage lysozymes19, but not capable of inhibit-
ing the enzymatic activity of fish g-type lysozymes20. However, a highly specific bacterial inhibitor of g-type (PliG) 
lysozymes was recently identified21.
Lysozymes are commonly found in combinations of two types in a species. Invertebrates typically have the 
i-type22 together with c- or g-type lysozymes. A surprising exception was the finding that protochordates carry 
multiple g-type genes, but no c- or i-types of lysozyme11. Most vertebrates studied to date possess both c-type 
and g-type genes13–15. The majority of reports on fish lysozymes show that these two types of lysozymes possess 
different roles and functions in antibacterial defense. Fish c-type genes are frequently expressed in a constitutively 
housekeeping fashion while g-type gene expression is stimulated in an infection-response manner by bacteria or 
bacterial components, although the Atlantic salmon shows the opposite lysozyme expression profile23.
A recent genome survey by Irwin14 identified 234 single or duplicated lysozyme g-type sequences from 118 
vertebrate species representing all vertebrate classes except cartilaginous fish. Phylogenetic analyses indicated 
that most of these gene duplicates are recent or lineage specific events. Genome sequences of two bony fish 
(gar and tilapia) revealed no g-type lysozyme genes, while single or multiple genes for the g-type were found 
in the genomes of other teleosts. The cod had the largest number of g-type lysozyme genes, with as many as 11 
potential genes with seven of these genes clustered on two scaffolds and the remaining four on separate contigs, 
a distribution making the exact numbering of functional genes uncertain. However, only two full-length cod 
g-type lysozyme genes, named LygF1b and LygF1d and residing on different scaffolds, could be deduced from 
the genome, and they apparently arose from a relatively recent cod lineage-specific gene duplication event14. 
LygF1b is identical to the previously reported cod lysozyme gene and its partly characterised antibacterial recom-
binant product24. This gene contains alternative transcription start sites that give rise to two gene products with 
or without an exon-1 encoded signal peptide for secretion. The sequence of the second g-type lysozyme, LygF1d, 
possesses substitutions at the active site residue14. The active site glutamate residue is crucial for catalytic activity 
and structural stability of g-type lysozymes. Substituting this residue with alanine, glutamine and aspartate abol-
ish (Ala and Gln) or drastically reduce (Asp) the lysozyme enzyme activity25. Thus, the Glu -> Ala substitution 
in LygF1d should prevent enzymatic activity. Furthermore, two aspartate residues nearby the active site in the 
LygF1b cod g-type lysozyme seem central to ensure that a water molecule is in a proper location to perform the 
nucleophilic attack during catalysis. Substitution of any of these two aspartates reduce the enzyme activity 10–300 
fold26.
No report so far has indicated the absence of a c-type lysozyme in cod or other gadoids. The present study 
shows that lysozyme activity from the cod belongs to the g-type only, and that sequence homology searches 
revealed a lack of c-type lysozyme genes in the cod genome. Analyses of four identified g-type lysozymes 
LygF1a-d demonstrated that multiple tissues express all four genes. Expression of only the two enzymatic 
low-active or inactive LygF1c and d are stimulated by an intracellular bacterium that commonly infects cod. This 
up-regulation is further enhanced by interferon gamma (IFNγ ). Expression of none of the genes is affected by the 
bacterial component lipopolysaccharide (LPS) suggesting an intracellular function for LygF1a, c and d.
Results
A goose-type lysozyme in gadoids was for the first time reported in 200924 and recently identified by Irwin as one 
(annotated LygF1b) out of 11 potential g-type lysozymes in cod14. There is, however, no work on gadoid c-type 
lysozymes published to this day. The present work focuses on identification of any cod lysozyme with apparent 
functional role based on enzyme/muramidase activity, protein structure, gene appearance, gene expression and 
expression regulation.
Identification of lysozymes genes in cod. Protein sequences of c-type lysozymes from chicken, human 
and eight fish species were used in TBLASTN searches for similar putative translation product sequences in the 
cod genome. Unexpectedly, these analyses revealed no indication for the presence of a c-type lysozyme gene in cod.
In contrast, BLAST searches using the previously identified g-type lysozyme from cod24 and salmon27 as 
query sequences identified three complete and one near-complete genes encoding the g-type lysozymes previ-
ously annotated as LygF1a-d14 (Fig. 1A) contained in gene scaffolds 3789 and 1808. Searches of EST databases 
identified multiple expressed sequences from each of the three cod genes LygF1b, c and d. Two ESTs that show 
5′ or 3′ sequence overlap with the partial LygF1a gene sequence allowed identification of a complete gene and 
the prediction of its complete encoded sequence. The extended LygF1a cDNA sequence indicated that the contig 
containing the previously annotated LygF1i sequence14 must be located near gene scaffold 3789, which encodes 
the remainder of LygF1a, in the cod genome. We also revealed a fifth potential full length cod g-type lysozyme 
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gene, previously designated LygF1j encoded by contig 58713414, but this gene was disregarded in the following 
work since no matching EST was found and we failed to identify any evidence for expression of this sequence.
Atlantic cod goose-type lysozyme proteins. The LygF1b gene has two alternative transcription start 
sites, one of which results in a product containing a signal peptide that would allow secretion24. No signal peptide 
sequences were identified for LygF1a, c and d. The multiple protein sequence alignment in Fig. 1A displays that 
the active site glutamate residue E71 in the previously reported enzymatic active LygF1b is replaced by alanine 
A71 in LygF1a and LygF1d. Except for the proline P88 substitution in LygF1c, aspartate residues D88 and D99 
involved in catalysis26 are conserved among the lysozymes. The predicted protein sequences of the cod g-type 
lysozymes suggest that only LygF1b and possibly LygF1c (although containing the aspartate → proline substitu-
tion; D88P) have enzymatic ability since LygF1a and d have mutated catalytic sites. Of worthwhile notice was one 
ESTs (EY974857.1) that matches LygF1d encodes a codon for glutamate at the position corresponding to E71, 
thus deviating from the A71 in the LygF1d gene, suggesting that this gene is polymorphic and that one allele may 
encode an active enzyme.
Figure 1. Atlantic cod g-type lysozyme proteins and electrostatic potential. (A) Alignment of cod g-type 
lysozyme protein sequences. Amino acid sequence alignment was generated with Clustal Omega, with the 
symbols below the alignment complete conservation (* ), sites with strongly conserved properties (:), and 
sites with weakly conserved properties (.). The sequences are numbered from the N-terminus of the mature 
LygF1b proteins, with the signal peptide in italic and numbered backwards. The catalytic residues equivalent 
to E73 (E71 in the cod LygF1a/LygF1b sequences) and D86 and D97 (D88 and D99 in the cod LygF1c/LygF1d 
sequences) in the g-type sequence are indicated, with residues compatible with enzymatic function in green and 
those that should prevent enzymatic activity shown in red. (B) Phylogenetic relationships of g-type lysozyme 
from cod and other fishes. A bootstrapped (1000 replications) neighbour-joining tree based on maximum 
composite likelihood distances was generated using MEGA6.254. Numbers at the nodes represent the number 
of bootstrap replicates (out of 1000) that supported each node. Branch lengths are proportional to amount of 
inferred change, with scale bar (changes per base) shown at the bottom. Trees were rooted based on previous 
phylogenetic analyses of g-type lysozyme sequences14. (C) 3-D models of LygF1a, LygF1c, and LygF1d were 
constructed based on the previously identified structure of LygF1b26 and the electrostatic surface potential is 
indicated in red (negative) and blue (positive). NAG molecules are presented as sticks docking into the LygF1 
models in correspondence with the observations in native LygF1b.
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The LygF1a sequence is most similar to LygF1b, sharing 96 and 95% identity at the DNA and protein lev-
els, respectively. LygF1c is closest to LygF1d in sequence (87 and 73% identical in DNA and protein sequence), 
with an average of 60% identity and 71% similarity seen between the two pairs of protein. All of the cod g-type 
lysozyme genes are more closely related to each other than to any other characterised fish g-type lysozyme 
sequence (Fig. 1B).
Cod lysozyme structures. Previous structure studies of cod LygF1b revealed the presence of NAG in the 
substrate binding sites B-D and E-G26 at both sides of the catalytic glutamate E71, and that the two aspartate 
residues (D88 and D99 in Fig. 1A) are central for binding and positioning of a water molecule serving as a nucleo-
phile and thus promoting muramidase activity26. To avoid speculations about potential enzymatic activity of 
LygF1a and d, carrying an alanine instead of a glutamate in the active site, we investigated the cod lysozyme 3-D 
structures based on models built from the crystal structure of LygF1b26. This investigation revealed only minor 
differences between the over-all structures of the four g-type lysozymes. As presented in Fig. 1C, the E-G binding 
cleft of LygF1c and d appears slightly wider than that of LygF1a and b and the charge of the surrounding surfaces 
are more negative in the LygF1c and d pair. Docking of NAG molecules, as observed in the native cod structure 
(PDB 3GXR), into the cod lysozyme binding clefts demonstrates sufficient space for ligand binding (ball and stick 
model in Fig. 1C). However, the static model provides no strong indication of any other residue nearby that can 
take over the nucleophilic role of E71 in LygF1a and d or that the expected negative effect of proline substitution 
of D88 in LygF1c is relieved by other residues. LygF1c displays additionally an even more open B-D binding site 
than the three others and carries several amino acid substitutions in the substrate binding sites compared to 
LygF1a, b and d in addition to the D88P substitution. Thus, it is possible that LygF1c has a substrate preference 
that may be different from LygF1a, b and d.
Lysozyme activity and gene expression in cod tissues. Lysozyme activities in extracts from spleen 
and head kidneys were determined in the absence and presence of the two specific bacterial lysozyme inhibitors 
Ivy and PliG21,28. All activity was suppressed in the presence of the g-type inhibitor PliG, while the Ivy c-type 
inhibitor had no effect on the lysozyme activity contained in these extracts (not shown). This shows that all 
measured lysozyme activity in these two organs arise from g-type lysozyme and at a level of 40–50 Units/mg total 
protein (Fig. 2A). No lysozyme activity was detected in the other organs examined.
PCR amplification of cDNA and subsequent sequencing of the four LygF1a-d lysozyme genes confirms their 
sequences as deposited in the cod genome database with one exception. Due to the discovery of an existing EST 
(EY974857.1) homologous to LygF1d, but carrying the active site glutamate residue, amplification products of 
LygF1d from four cod individuals were sequenced and one of the four confirmed the presence of this active site 
variant of LygF1d. We have no data on how frequent this presumably enzymatic active LygF1d variant occurs in 
nature.
The gene sequence of LygF1a differs from LygF1b in only 23 out of 564 nucleotides in positions scattered 
throughout the gene. This nearly full sequence identity represents a significant obstacle in analyses to discrimi-
native gene expression of these two particular genes, although the longer 5′ gene sequence of the secreted form of 
LygF1b (including the encoded signal peptide) permits design of primers that selectively amplify its transcript. 
Initial work showed that PCR analyses of LygF1a gave significant footprints of LygF1b (secreted and non-secreted 
forms) as revealed by direct sequencing the respective amplified products. Even in the case of discriminating 
LygF1c from d, real time PCR co-amplification was observed although the DNA sequence identity between 
LygF1c and d is lower than between LygF1a and b. Thus, the following expression analyses ran primarily with 
primers that direct the co-amplification of LygF1a + b and of LygF1c + d. Consequently, we have also not tried to 
distinguish the two LygF1d variants regarding active site residue E71 or A71.
Real time PCR analyses revealed that both pair of genes LygF1a + b and LygF1c + d are expressed in all cod 
tissues albeit at different levels. The hematopoietic organs, head kidney and spleen, showed the highest expres-
sion of LygF1a + b where also lysozyme activity was detected (Fig. 2A). Although lysozyme activity was detected 
only in head kidneys and spleen, g-type lysozyme gene expression dominated by LygF1c and d is considerable in 
organs such as gills and blood.
Expression of two other antibacterial genes, cathelicidin and hepcidin, was included in this tissue distribution 
study for comparison to lysozyme (Fig. 2B). Cathelicidin is expressed at a significantly higher level (5–10-fold) 
than hepcidin in the hematopoietic organs.
Gene expression after LPS treatment. We have recently shown that in vitro and in vivo expression 
of Atlantic cod hepcidin and cathelicidin is highly induced by LPS29, a commonly used bacterial Pathogen 
Associated Molecular Pattern (PAMP), and that in vitro expression of Atlantic salmon c-type lysozyme unlike the 
g-type is enhanced in the presence of LPS23. Here, gene expression of the cod g-type lysozymes was studied after 
injection of crude E. coli LPS into live fish or after co-incubating macrophages with LPS. No LPS-inducible cod 
g-type lysozyme expression was detected in head kidneys tissue samples or in the macrophages (Fig. 3). Similarly, 
crude LPS isolated from F. noatunensis had no effect on the in vivo expression of lysozyme in cod (not shown).
Gene expression after F. noatunensis infection in vivo. Atlantic cod were injected i.p. with the faculta-
tive intracellular bacteria F. noatunensis to study the responding effect on the transcription of antibacterial genes 
in the host. Somewhat surprisingly, gene expression of LygF1a + b was significantly down-regulated 1–7 days after 
injection of bacteria. LygF1c + d expression, on the other hand, was significantly up-regulated at 2, 4 and 7 days 
after injection (Fig. 4A). In the amplified LygF1c + d pair, both genes have higher expression levels in infected 
cod although LygF1d appeared to have the highest increase in expression. Expression of both antibacterial genes 
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cathelicidin and hepcidin was significantly up-regulated after injection of bacteria, but returned to lower expres-
sion levels earlier than LygF1c + d (Fig. 4B).
Effect of F. noatunensis infection and IFNγ on lysozyme gene expression in vitro. An infection 
study with F. noatunensis was also performed in cod macrophages and the decreased LygF1a + b expression (rel-
ative to uninfected control cells) seen in vivo following infection was less evident in vitro (Fig. 5). However, the 
bacteria-induced increase in LygF1c and d expression observed in vivo was reproduced in the in vitro cultures. 
Expression levels of all cod g-type lysozyme genes progressed in control cell cultures during the experimental 
period indicating an augmented amount of lysozyme as the macrophages mature.
The type II interferon IFNγ has a profound signalling and modulatory function on immune-related net-
works of genes and associated pathways30. Our studies showed that IFNγ mediated a stimulation of LygF1c + d 
in cod macrophages, while LygF1a and b expression remained at the control levels (Fig. 5). Evidently, IFNγ 
also enhanced the already stimulated expression of the LygF1c and d genes in cod macrophages infected with 
F. noatunensis, whereas LygF1a and b expression did not change in the IFNγ -treated infected cells. Hepcidin 
and cathelicidin expression was apparently unaffected by IFNγ and the slightly increased expression of hepcidin 
observed in cells infected by F. noatunensis was not statistically significant.
Discussion
With a few exceptions, vertebrate genomes typically harbour both c-type and g-type lysozyme genes13,14. No 
g-type gene was found in tilapia, gar, and elephant shark genomes, while c-type lysozyme genes were not found 
in the avian zebra finch or the jawless lamprey fish13,14. However, these genes may exist in gaps in the available 
genome sequences of these species. Lysozyme activity has been described in a wide variety of vertebrates, never-
theless, the function of c-type lysozymes have been better characterised than of g-type lysozymes15,31. Although 
g-type lysozyme genes exist in diverse vertebrates, characterisation of g-type activity is dominantly from birds 
and fish. In contrast, c-type lysozyme activity is extensively studied in a wide variety of vertebrates15,31. Deficiency 
of c-type lysozyme has previously been reported in a few vertebrate species (e.g., birds, cow and rabbit32–36). For 
the mammalian species, these deficiencies were tissue-specific, with lysozyme being absent (or very low) in blood, 
tears, and/or milk, but with c-type lysozyme activity detected in other tissues32–34,37. Studies in birds have been 
Figure 2. Constitutive expression of antibacterial genes in cod organs. Atlantic cod (100 g) head kidney 
(Hk), spleen (Sp), gills (Gi), liver (L), skin (Sk), heart (He), peritoneum (P), gonads (Go), blood (B) and 
intestine (I) were sampled and subjected to real time PCR analysis of gene expression for (A) g-type lysozymes 
LygF1ab and LygF1cd, and for (B) cathelicidin and hepcidin. Expression was normalised to the geometric mean 
of the reference genes (elongation factor eF1a, ubiquitin and 18S RNA) and calibrated to the organ (gonads) 
with lowest level of expression of antibacterial genes. Results are shown as relative quantification values 
obtained from four fish with mean quantity and calculated SEM. Total lysozyme enzyme activity measured 
is presented as Units mg−1 of total protein in spleen and head kidney (A) and is of the g-type exclusively. No 
lysozyme activity was detected in the other organs.
www.nature.com/scientificreports/
6Scientific RepoRts | 6:28318 | DOI: 10.1038/srep28318
more limited, with only egg-white examined in many species. Both c-type and g-type lysozymes are found in 
eggs, but in most species, only one but not the other35,38,39. Genome searches for avian lysozyme genes revealed 
the presence of g-type lysozyme genes in all 6 species examined14, while c-type lysozymes were found in only 3 of 
4 species examined13, raising the possibility that the some birds, such as the zebra finch, may be missing a c-type 
lysozyme gene. Further searches of the genome and transcriptome of these birds, as well as examinations for 
enzymatic activity are needed to confirm the loss of the c-type lysozyme gene.
Here we conducted a more detailed examination of the genome, transcripts, and enzymes, and demonstrate 
for the first time a species, the cod, which truly lacks a c-type lysozyme gene. Despite previously demonstrated 
peculiarities in the cod immune system4, the present finding of a missing c-type lysozyme gene was quite unex-
pected. Cod differs from other teleost species in having highly amplified the g-type lysozyme gene, while the 
c-type lysozyme gene is absent in the cod genome. Intriguingly, a similar situation occurred in ruminant artio-
dactyl mammals, where the LygA1 gene (a g-type lysozyme gene) was pseudogenized in parallel with the amplifi-
cation of the c-type lysozyme gene14. These parallels suggest that amplification of one type of lysozyme gene may 
allow generation of redundant copies that can be neo-functionalized to replace the function of the second type of 
lysozyme gene, and allow the pseudogenization and/or gene loss of the second type of gene.
In contrast to LygF1b, the other intact g-type lysozyme genes in the cod carry either a substitution of the 
glutamate E71 (E71A in LygF1a and d) nucleophile positioned in the substrate binding cleft, or of the aspartate 
88 (D88P in LygF1c) involved in water binding and catalysis that are conserved in enzymatically active g-type 
lysozymes25,26. Our structure models of these g-type lysozymes fail to identify any other nearby residues that 
are judged to have nucleophilic capacity to replace the role of E71 in catalysis. In other words, the primary and 
tertiary structures of LygF1a and d are not consistent with lysozyme enzyme activity according to the generally 
accepted catalytic mechanism and particularly according to the verified crucial role of E71 for catalysis by g-type 
lysozymes25. Furthermore, site-specific substitution of D88 in LygF1b with an alanine was earlier demonstrated 
Figure 3. Gene expression of lysozymes in cod subjected to LPS. (A) Atlantic cod (approx. 50 g) were injected 
with 1 mg/kg crude (Cr) E. coli (Ec) LPS (0111:B4) or control (0.9% NaCl). Head kidney were sampled after 
8 h, 1, 2, 4 and 7 days and subjected to real time PCR analysis of the LygF1 lysozymes. Expression of target 
genes were normalised to 18S RNA expression and calibrated to non-injected fish. Results are shown as relative 
quantification values obtained from six fish with mean quantity and calculated SEM. (B) Monocytes/macrophages  
were stimulated with Cr-Ec0111:B4 or left untreated (Ctr) and analysed for gene expression after 6, 12, 24, 48 
and 72 h. Expression of target genes were normalised to eF1a expression and calibrated to untreated control 
at 6 h. Results are shown as relative quantification values obtained from four fish with mean quantity and 
calculated SEM.
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to result in a 10-fold reduction of enzyme activity26, and the D88P substitution in LygF1c is expected to have at 
least similar negative impact on the enzyme activity.
The finding of a LygF1d variant carrying E71, and thus a presumably active enzyme, instead of A71 that 
removes activity is highly interesting. We have not conducted detailed studies on the relative expression between 
the two variants in the examined tissues. However, we are tempted to suggest that the LygF1d variant carrying E71 
represents a minor allele based on the tissues distribution of lysozyme activity. From an evolutionary perspec-
tive, the LygF1d gene might represent an evolutionary intermediate that is undergoing the loss of muramidase 
activity, through the E71A substitution along with other possible amino acid substitutions, which is tolerated in 
cod due to the duplications of the g-type lysozyme genes and retention of a functional LygF1b gene that encodes 
muramidase activity.
Head kidney of the cod contains high levels of lysozyme enzymatic activity and our expression analyses shows 
that the LygF1b (or LygF1a + b) transcript level is almost 10 fold higher than LygF1c + d. Similar high levels of 
constitutive LygF1a + b and LygF1c + d gene expression were detected in the spleen. Other organs, e.g., gills and 
blood, contained LygF1c + d transcript levels equal to or slightly lower than the spleen, and with low levels for 
LygF1a + b. Detectable lysozyme enzymatic activity was only present in the head kidney and the spleen, organs 
where LygF1b (or LygF1a + b) expression dominates. These analyses are consistent with our conclusion that 
LygF1a, c and d are enzymatically inactive or low-active lysozymes, as suggested earlier for LygF1d14. We cannot 
exclude the possibility that there are additional functional cod g-type lysozymes among the remaining potential 
genes14, although BLAST searches of EST databases revealed no evidence for expression of any of these genes.
Unlike cod antibacterial hepcidin and cathelicidin29 and g- or c-type lysozymes of other fish species23, none of 
the cod lysozymes were transcriptional modulated by in vitro or in vivo administration of the bacterial cell wall 
LPS component. This does not necessarily mean that LPS has no immunomodulating effect on these lysozyme 
genes, e.g. these genes may require the mediation of LPS signals through intracellular routes different from those 
used by hepcidin and cathelicidin. If so, this is consistent with the idea that the studied g-type lysozymes have an 
intracellular role since they are clearly down or up-regulated by an intracellular infection.
Figure 4. Expression of antibacterial genes in Atlantic cod head kidney after injection with F. noatunensis. 
Atlantic cod (approx. 25 g) were injected with 5 × 107 F. noatunensis (F.n.) or control (0.9% NaCl). Head kidney 
were sampled after 6 h, 1, 2, 4 and 7 days and subjected to real time PCR analysis of (A) LygF1ab and LygF1cd 
lysozymes, and of (B) cathelicidin and hepcidin. Expression of target genes were normalised to 18S RNA 
expression and calibrated to non-injected fish. Results are shown as relative quantification values obtained from 
six fish with mean quantity and calculated SEM. The asterisks above columns indicate significant differences 
(p < 0.05) compared to the control at the same sampling point.
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Judged by previously reported real time PCR and “semi-quantitative PCR” experiments, formalin-inactivated 
and extracellular Gram-negative bacteria result in a slight increase in LygF1b transcription24,40. In the present 
Figure 5. Antibacterial gene expression in monocytes/macrophages stimulated with IFNγ and infected 
with F. noatunensis. (A) Monocytes/macrophages were treated with recombinant IFNγ or recombinant control 
(rCtr; back-ground proteins isolated from E. coli containing an empty vector) and analysed for gene expression 
of g-type lysozymes (LygF1a + b and LygF1c + d) and antibacterial genes (cathelicidin and hepcidin). (B,C) 
Monocytes/macrophages were either infected with F. noatunensis (F.n.), pre-treated by recombinant rCtr 
or IFNγ prior to infection or left un-treated (Ctr) and subjected  to gene expression of analyses (B) g-type 
lysozymes (LygF1a + b and LygF1c + d) and (C) and antibacterial genes (cathelicidin and hepcidin). Expression 
of target genes were normalised to eF1a expression and calibrated to the Ctr cells at 6 h. Results are shown as 
relative quantification values obtained from four fish with mean quantity and calculated SEM. The asterisks 
above columns indicate significant differences (p < 0.05) compared to the F. noatunensis infected cells at the 
same sampling point.
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study, infecting cod with facultative intracellular F. noatunensis provoked gene expression responses by both 
LygF1a + b and LygF1c + d, although they were in opposite directions. Recombinant IFNγ produced a similar 
in vitro stimulatory effect on LygF1c + d gene expression as seen by bacterial infection, with this cytokine giving a 
significant additive effect on LygF1c + d expression in infected cells. Thus, the LygF1c and d gene “pair” evidently 
responds as expected for genes of importance in an antibacterial system or pathway. Hepcidin and cathelicidin 
was, however, not affected by IFNγ or by infection.
IFNγ is acknowledged as a key activator of cell mediated immunity and especially important in defence against 
intracellular pathogens41. Another bactericidal mechanism induced by IFNγ is the production of different anti-
microbial peptides (AMPs)42 and lysozyme43. While most AMPs are either secreted or delivered to phagosomes, 
AMPs are also found localised in cytosol44,45. F. noatunensis enters cod macrophages in membrane-enclosed vac-
uoles and most likely escapes to the cytosol for replication46 similar to F. tularensis. The observed gene expression 
kinetics for LygF1c + d thus could be consistent with a role for this lysozyme in inhibiting the intracellular growth 
of F. noatunensis. There are no previous reports on a differential influence of IFNγ on g-type lysozymes, but the 
challenge responses observed here support our conclusion that cod LygF1c and d possess qualities preferred, 
perhaps more than of the enzymatic active LygF1b, for the defence against intracellular bacteria. The mechanisms 
limiting cytosolic growth of bacteria are not well understood, but intracellular localised lysozyme in concert with 
IFNγ might serve an important role in controlling intracellular growth of Francisella, a hypothesis that deserves 
further investigation.
Duplication of the g-type lysozyme genes and retention of non-secreted isozymes that have lost enzymatic 
activity was proposed to indicate that these lysozymes had roles other than being an antibacterial enzyme through 
its associated muramidase activity14. Evidence for a potential function for these lysozymes come from the obser-
vations of significant antibacterial activity in enzymatically-inactivated lysozymes17 and for proteolytic fragments, 
or synthetic peptides, derived from lysozyme proteins18. In these cases, the membrane-penetrating capacity of the 
lysozyme or lysozyme-derived fragment mediates the antibacterial action. Lysozymes also promote aggregation 
of bacteria by binding to the bacterial surfaces47. Aggregation per se may have limited antibacterial effects, but it 
will ease the recognition and engulfment of lysozyme-bound bacteria.
Bacteria are one of the targets of selective autophagy, and this process is known as xenophagy (degradation 
of microorganisms). In this context, autophagy acts as an innate immune mechanism against bacterial infection. 
Autophagy paradoxically also represents a survival/escape route for some pathogens48. Extensive work has been 
done to determine the induction and targeting mechanisms of antibacterial autophagy believed to involve acti-
vation of multiple host factors and pathways. Selective autophagy implies cargo selection mediated by various 
receptors and adaptor proteins. For instance, the autophagy receptor p62 links various ubiquitinated cargo targets 
including bacteria to autophagosomes49, and NBR1 is involved as adaptor for the bacterial pathogen F. tularen-
sis50. The existence of multiple intracellular cod g-type lysozymes with no or very low enzyme activities, and the 
demonstrated modulation of lysozyme gene expression by bacterial infection and IFNγ , allows speculations about 
a possible role for lysozymes in the process of selective autophagy of bacteria.
The four cod g-type lysozymes investigated in this study are LygF1a-d of which only LygF1b was previously 
identified as an active enzyme24, while the recent characterisation of LygF1d was restricted to comparative 
sequence analyses14. Our results show that the LygF1a, c and d genes are constitutively expressed at a significant 
level in all organs examined, and the level of expression was even higher than that of LygF1b in several of the 
organs. Based on the antibacterial nature of lysozymes, or at least their indisputable part in the innate defense 
system, the wide tissue distribution of the non-enzymatic or low-active LygF1a, c and d strongly suggests that 
these g-type lysozymes have functional roles in cod innate immunity. As shown by infection studies, regulation of 
gene expression differed from LygF1a + b to LygF1c + d, and modelled 3-D structures implied some differences 
in substrate binding capacities, in particular for LygF1c. Taken together, this indicates not only that the multiple 
g-type lysozymes play functional roles, but also that their roles differ.
The present work shows that c-type lysozyme is not an essential enzyme, although duplication of the g-type 
lysozyme may have allowed the evolution of a g-type lysozyme that could functionally replace the missing c-type 
lysozyme. Which of the four g-type lysozymes, the enzymatically active or those inactivated by active site substi-
tutions, is functionally compensating for the loss of the c-type lysozyme still needs to be identified. Studies in spe-
cies related to the cod should help, by determining the times of the loss of the c-type lysozyme gene, duplication 
of the g-type lysozyme genes, and the mutational changes that prevent enzymatic activity.
Materials and Methods
Search for c- and g-type lysozyme genes and transcripts. Searches for c- and g-type lysozymes 
sequences using the basic local alignment search tool (TBLASTN51) were performed on the Ensembl Atlantic 
cod genome database (http://www.ensembl.org/Gadus_morhua) and in the European Nucleotide Archive (ENA) 
for expressed sequence tags using NCBI BLAST+ (http://www.ebi.ac.uk/Tools/sss/ncbiblast/nucleotide.html). In 
the searches for cod c-type genes or transcripts, a panel of c-type query sequences from the following sources 
were employed; fugu (P61944), starry flounder (BAL44624.1), spotted green pufferfish (AG06232.1), Senegalese 
sole (ABC49680.1), turbot (CE80211.1), rainbow trout (AF321519.1), zebrafish (NP631919.1), Atlantic salmon 
(ACM09320.1), human (NP000230.1) and chicken (P00698). Similar searches for g-type lysozymes were con-
ducted using a previously characterised cod g-type lysozyme (EU37760624) and the Atlantic salmon g-type 
lysozyme (CAM3543127). A multiple sequence alignment of the proteins was constructed using Clustal Omega 
with default settings52 and subsequently edited using GeneDoc, version 2.753.
Phylogenetic analysis. Phylogenetic relationships among the cod sequences and g-type lysozymes from 
other fish were assessed using the neighbour-joining method using MEGA6.254. Nucleotide sequences of g-type 
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lysozyme from cod and other fish were aligned at the codon level (to maintain coding potential) using Muscle 
as implemented in MEGA6.254. Bootstrapped neighbour-joining trees, 1000 replications, were generated using 
maximum composite likelihood distances. Trees were rooted based on previous phylogenetic analyses of g-type 
lysozyme sequences14.
3-D structure modelling. Homology models of LygF1a, c and d were generated by feeding the edited align-
ment and native structure of cod lysozyme (PDB 3GXK26) into the Maestro v9.4 option of the Schrödinger soft-
ware (Schrödinger, LLC, NY, 2013).
Cod tissue sampling. Atlantic cod (100 g; n = 4), healthy and without any signs of disease, were obtained 
from the Aquaculture Research Station (Tromsø, Norway). The use of live Atlantic cod was approved by the 
National Animal Research authority in Norway and all methods were in accordance with the approved guidelines. 
The fish were kept in circular 1500 L tanks in seawater (3.4%) at natural seawater temperature (3–9 °C) and fed ad 
libitum with commercial feed (Amber Neptun; Skretting) under a 24 hour light regime. Fish used for our studies 
were rapidly killed and blood was removed by bleeding the fish from the Vena caudalis. Following sampling, 
cod organs (head kidney, spleen, gills, intestine, liver, skin, heart and peritoneum) were split in two parts and 
submerged in RNAlater (Ambion) for subsequent gene expression studies or stored at − 20 °C for later enzyme 
activity measurements. Blood for gene expression studies was sampled in 1x lysis buffer (Applied Biosystems).
Lysozyme activity measurements. After thawing on ice, tissue samples were homogenized in 0.5 ml or 
1 ml of 0.1 M sodium acetate buffer, pH 6, using a Polytronic PT 1200 handheld device. The extracts were then 
centrifuged at 20,000 × g for 20 min and the supernatants subsequently subjected to lysozyme activity measure-
ments. Assays were run at 22 °C using 0.3 mg/ml lyophilised Micrococcus luteus as a substrate in sodium acetate 
buffer (0.1 M; pH 4.8) and subsequent recording of change in absorbance at 450 nm with time. One unit of activity 
was defined as the amount of enzyme that catalyses a decrease in absorbance of 0.001 min−1. The effect of bacte-
rial lysozyme inhibitors on tissue lysozyme activity was performed in the same assay using 1 μ g of the bacterial 
inhibitors of c-type lysozyme (Ivy) or g-type lysozyme (PliG)21,28 representing an excessive concentration com-
pared to the contained lysozyme activities. The inhibitors were included in the substrate mixture before adding 
enzyme-containing extract for recording of activity.
Isolation of monocyte/macrophages from Atlantic cod. Head kidney derived macrophages were iso-
lated from cod based on previously described protocols. In short, head kidneys were aseptically removed and 
transferred to L-15+ + (L-15 (Gibco, Invitrogen or PAA Laboratories) supplemented with 25 mM HEPES, 2 mM 
l-glutamine, 13.7 mM NaCl, 1.8 mM glucose, 4.2 mM NaHCO3, 20 U/ml penicillin, 20 μ g/ml streptomycin and 
10 U/ml heparin (LEO Pharma AS)). Head kidney were homogenised (GentleMACSTM dissociator, Miltenyi 
Biotec) and minced through a 100 μ m nylon Falcon cell strainer (BD Bioscience) and diluted in 90 ml L-15+ + . 
Cell suspensions were loaded on discontinuous 28%/45% Percol (GE Healthcare) gradients and separated by 
centrifugation at 400 × g for 40 min at 4 °C. The interphase containing purified macrophages was washed twice in 
50 ml L-15+ (L-15+ + without heparin) followed by centrifugation at 300 × g for 10 min at 4 °C. In the last wash-
ing step, cells were diluted in L-15+ and seeded at a density of 5–10 × 106 cells per well in 24-well culture plates 
(Nunc or BD Biosciences). Covered by Microplate sealing Tape (Nunc), the culture plates were incubated at 12 °C 
to the following day when cells were washed twice in L-15+ for further studies.
Stimulation of cod monocytes/macrophages with LPS. Stimulation of primary cultures with LPS 
is described elsewhere29. In short, monocyte/ macrophage cultures (n = 4) were stimulated with 20 μ g/ml crude 
E. coli LPS (0111:B4; Sigma-Aldrich) for sequential time points (6, 12, 24, 48 and 72 h) and cells were harvested 
by adding 1x lysis buffer (Applied Biosystems). All samples were stored at − 80 °C for further gene expression 
analysis as described below.
Injection of Atlantic cod with LPS. Fish (approx. 50 g) kept at 10 °C were fed ad libitum using a com-
mercial feed (Amber Neptun; Skretting). The in vivo injection study has been described previously29 and was 
approved by the National Animal Research authority in Norway (FOTS Id 3033). In short, cod were anaesthetised 
with Metacainum (50 mg/l, Norsk Medisinaldepot) and injected intraperitoneally (ip) with 100 μ l of 0.9% NaCl 
(Ctr) and crude E. coli LPS (0111:B4; 2 mg/kg) diluted in 0.9% NaCl. A control group that was not injected was 
also sampled. Fish (n = 6 for each time point) were sampled after 8 h, 1, 2, 4 and 7 days in RNA-later (Ambion), 
kept at 4 °C overnight before storage at − 80 °C.
Injection of Atlantic cod with F. noantunensis. The Francisella noatuensis subsp. noatuensis NCIMB 
1426555 isolate used for challenge was originally isolated from diseased Atlantic cod (Gadus morhua) in Norway, 
and were provided by Dr. Duncan Colquhoun at the National Veterinary Institute Oslo, Norway. The bacteria 
were cultivated at 21 °C for 7–10 days on CHAB agar56 and heart infusion broth (Merck) pH 6.8 ± 0.2, supple-
mented with cysteine 0.1% (Merck, Germany), haemoglobin (Oxoid, England), 2%, glucose 1%, agar 1.5% and 
5% human blood concentrate. The bacterium was stored in glycerol cultures at − 80 °C. Pure colonies were inoc-
ulated in Bacto heart infusion broth (Becton and Dickson, USA) pH 7, supplemented with cysteine 0.07%, FeCl3 
2 mM and glucose 1%, and incubated with agitation at 21 °C for 24–30 hours before used in the challenge study. 
CHAB plates were used for determination of colony forming units (cfu) of challenge dose. The fish were reported 
to be healthy without any history of diseases and all efforts were made to minimise suffering. The experiment was 
approved by the National Animal Research authority in Norway (FOTS Id 1147).
www.nature.com/scientificreports/
1 1Scientific RepoRts | 6:28318 | DOI: 10.1038/srep28318
Fish (approx. 25 g) acclimated to 15 °C and starved 24 h were anaesthetised with Metacainum (50 mg/l, Norsk 
Medisinaldepot) prior to i.p. injection (100 μ l) of either F. noatunensis (5 × 107 cfu per fish) or 0.9% NaCl (con-
trol). At fixed time intervals after injection, fish were rapidly killed and blood was removed by bleeding the fish 
from the Vena caudalis. Head kidney (n = 6 for each time point) were sampled at 0, 6 hours, 1, 2, 4 and 7 days post 
infection. No mortality was recorded in any of the tanks.
Recombinant production of IFNγ and activation of macrophages. The open reading frame of the 
DNA sequence for cod IFNγ (accession number FJ356236.1) was inserted into the expression vector pUC57 con-
taining an N-terminal 6-His tag (Genscript, NJ). To allow expression of the recombinant protein, the plasmid was 
transformed into E. coli cells and recombinant (r) IFNγ was purified using Ni-HiTrap column (Genscript, NJ). 
The purified protein was resolved by 4–20% SDS-PAGE and visualised by Coomassie Blue staining. Protein con-
centration was determined by comparing the protein band density with a standard protein. Western blot analysis 
was performed to confirm the identity of the rIFNγ using Anti-His antibody revealing a single band. A plasmid 
without insert was transformed into E. coli and the bacterial extract was purified similarly as rIFNγ to be used as 
control in the in vitro experiments (rCtr). The endotoxin level was determined to be < 0.25 Eu/μ g LPS by the LAL 
method. In order to study the induction of gene expression by rIFNγ , isolated macrophages (n = 4) were treated 
for 24 h with 1000 ng/ml rIFNγ and rCtr (diluted similarly). Cells were harvested in 1x lysis buffer (Applied 
Biosystems) and RNA was isolated for gene expression analysis of LygF1a + b and LygF1c + d as described below.
Infection of cod monocytes/macrophages with F. noantunensis. Monocyte/macrophage cultures 
(n = 4) were pre-treated for 24 h with IFNγ at a concentration of 1000 ng/ml or left un-treated (Ctr). Cells were 
infected with F. noatunensis (NCIMB 14265) diluted in L-15+ with 5% FBS Gold (PAA) at a multiplicity of infec-
tion (MOI) of 50–100. Uninfected cells were incubated with cell media/FBS Gold alone and treated otherwise 
similarly as infected cells. The cell culture plates were centrifuged (500 × g, 5 min) to enhance the initial contact 
with the cells. Two hours after infection, the cells were washed three times in L-15+ + and pulse-treated for 1 h 
with 50 μ g/ml gentamicin (Sigma-Aldrich) to kill extracellular bacteria. The cells were washed three times to 
remove gentamicin and fresh media supplemented with 5 μ g/ml gentamicin (Sigma-Aldrich) were added. Cell 
cultures were further incubated before harvesting in 1x lysis buffer (Applied Biosystems) at sequential time points 
(6, 10, 24, 48 and 72 h). All samples were stored at − 80 °C for further gene expression analysis as described below.
Gene expression analysis. Cells were harvested in 1x Nucleic Acid Purification Lysis buffer as described 
above, while tissues were homogenised in 1x lysis buffer using MagNA Lyser Green Beads and the MagNa Lyser 
Instrument (Roche Diagnostics). Total RNA was isolated using an ABI Prism 6100 Nucleic Acid Prep Station 
(Applied Biosystems) with the recommended on-column DNAse treatment. Reverse transcription was per-
formed using the High capacity RNA to cDNA master mix or High capacity cDNA reverse transcription kit 
(Applied Biosystems) with the addition of 2.5 mM poly dT primer (Promega). The reaction conditions were 
25 °C (5–10 min), 42 °C (60–120 min) and 85 °C (5 min) and the cDNA was diluted 1:30 in nuclease free water 
(Ambion) for further use in quantitative real time PCR. The absence of genomic DNA in the RNA was verified 
by real time PCR analyses without prior cDNA synthesis on a selection of samples from each experiment. Real 
time PCR was performed in duplicates in 384 well plates using the 7900HT Fast real-time PCR system and Power 
SYBR green PCR master mix according to the manufacturers description (Applied Biosystems). Real time PCR 
primers are listed in Table 1 with references for previous publications or as GenBank accession numbers for prim-
ers designed for this study. Gene expression data were analysed with the SDS 2.3 software (Applied Biosystems) 
and exported to Microsoft Excel for further analysis. The efficiency of the PCR reactions was determined by linear 
Gene name Sequence (5′-3′)
PCR 
efficiency/r2 Reference
LygF1b (secreted) GAGTTCAAGCCAATCTCCAAGATATT 95.5%/1.000 This study
(EU377606) GATGTCTCCGTACCCTACAGAATGA 
LygF1a + b TTCGCGACAGGATAAACTGGA 96.2%/0.999 This study
(EU377606) TTGTATTTTTCCATTCTCCCAGC
LygF1c + d GGCCAACCATGATTTGGCTT 94.7% /0.999 This study
(ENSGMOT00000015279) AGCTGGGTCAACATTACGTCTGC
Cathelicidin CACAAGAGTTAGACTGCAGCCAAG 96.2%/1.000 58
(EU707291.1) TGTAGCTCAGGGTGAAATTGCAAT
Hepcidin CCAGAGCTGCGGATCGA 99.4%/1.000 59
(EU334514.1) AAGGCGAGCACGAGTGTCA
Elongation factor 1α ATGTGAGCGGTGTGGCAATC 96.4%/1.000 60
(DQ402371.1) TCATCATCCTGAACCACCCTG
Ribosomal RNA (18S) GAGCCTAGAAATGGCTACCACATC 93.3%/0.998 60
(U11437.1) CACGTGTCGTGAATGGGTAATT
Ubiquitin GCCGCAAAGATGCAGAT 91.2%/0.995 61
(EX735613) CTGGGCTCGACCTCAAGAGT
Table 1.  Real time PCR primers, PCR efficiency and correlation coefficient (r2).
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regression analysis of 2-fold dilutions of cDNA (total RNA isolated from cod head kidney) and denoted with a 
correlation coefficient (r2). Quantification of relative gene expression levels were performed using the 2−∆∆CT 
method57. For quantification of target genes expression among different organs, the geometric mean of the three 
reference genes elongation factor 1α (eF1a), ubiquitin and 18S RNA was used for normalisation, while eF1a and 
18S RNA was used for normalisation of in vitro and in vivo expression experiments, respectively. After normali-
sation, the expression level was calibrated to non-stimulated/non-infected or uninfected controls. From relative 
quantification values obtained from cells or fish, the mean quantity ± SEM was calculated. Statistical analyses 
between groups were made with the Student t-test and P < 0.05 was considered significant.
DNA Sequencing. Sequence analysis of the four lysozyme transcripts was performed on cDNA (1/50 
dilution) from the different experiments in this study. Transcripts regions were amplified by PCR using a 
combination of specific primers and mutual primers. Primer sequences were as follows: LygF1a; Lyg1Fa-26F 
(5′ -TCAAACCGATGCTCGGAGG-3′ ) and LygF1ab-560R (5′ -CTAAAACCCGTTTTTTTTGTACC-3′), LygF1b; 
Lyg1Fb-197F (5′-CTCAAACCGATGCTGGGAGA-3′) and LygF1ab-560R (5′ -CTAAAACCCGTTTTTTT 
TGTACC-3 ′), LygF1c; Lyg1Fc-132F (5 ′-TGGTGTACAGGCATCGGAAA-3 ′) and LygF1c-537R 
(5′ -CTAAAACCCGTTTCGTTTGTAAA-3′), LygF1d; Lyg1Fd-133F (5′ -GGTGTACAGGCATCGCGAGA-3′) 
and LygFd-576R (5′ -CTAAAACCCGTTTTGTTTGTAAAA-3′).
PCR was carried out using Q5 high-fidelity 1x master mix (New England Biolabs) and 500 nM of each primer 
(Sigma-Aldrich) in a total volume of 25 μ l. The PCR thermal conditions were initial denaturation at 96 °C for 
30 s and 35 cycles at 96 °C for 5 s, 60 °C for 10 s, 72 °C for 20 s followed by a final extension at 72 °C for 2 min. 
Non-incorporated primers and nucleotides were digested with HT ExoSAP-IT (Affymetrix USB) according to 
the manufacturer recommendations.
Sequencing was performed on an ABI 3130xl genetic analyzer (Applied Biosystems) using the Big Dye 
Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems) according to the manufacturers instructions. 
Sequencing primers were identical to the PCR-primers. The obtained sequences were aligned using the SeqMan 
program within the Lasergene software package (DNASTAR Inc).
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